ノルウェーの成人外傷患者における国家治療ガイドラインに基づく標準治療への補助として、個別化された患者情報と自主的な患者管理型外来デジタルフォローアップ(I-POD)の有効性を評価するための無作為化比較臨床試験。 (POSTRAUMA)
ノルウェーの成人外傷患者における、国家ガイドラインに基づく標準治療の補助として、個別化された患者情報および患者管理による外来デジタルフォローアップ(任意参加)の有効性を評価するための無作為化比較臨床試験(POSTRAUMA試験)。
The POSTRAUMA trial is a clinical trial at The Regional trauma centre of Western Norway, Haukeland University Hospital.
Trauma is the leading cause of death worldwide in patients aged 1-45 years. In Norway, approximately 10,000 patients are admitted to hospital annually due to trauma, with 66% being male. The mean age is 43 years for male and 48 years for female, indicating a relatively young patient population.
While mortality rates are decreasing, a significant proportion of trauma survivors experience long-term disabilities, reduced quality of life, and difficulties in returning to work. These consequences impose substantial burdens on individuals, families, and society. Considering these issues, a shift in focus is needed-from survival alone to long-term functional recovery and quality of life after trauma.
Severe trauma often requires long-term follow-up, both physically and psychosocially. Traditional follow-up can be fragmented and not tailored to individual needs. Digital patient monitoring and tailored information have the potential to improve patient pathways, but knowledge about how these are experienced by patients is limited.
The goal is to find out if Norwegian trauma patients who receive tailored patient information and patient-managed outpatient digital follow-up, in addition to standard treatment have:
- Less disability
- Return more often to work
- Improved quality of life
The study population are Norwegian trauma patients, 16 years or older at date of inclusion, who are admitted to Haukeland University hospital (HUS) following trauma with trauma team activation. 256 patients will be included in this trial.
Participants will:
- Answer a questionnaire at inclusion, one month, 6 months and 12 months.
- Participants in the intervention group will be invited to digital outpatient follow up one month after the accident.
- Some participants will be interviewed about how they experienced their trauma follow up.
調査の概要
状態
詳細な説明
Trauma is the leading cause of death worldwide in patients aged 1-45 years. Injuries and violence contribute to approximately 10% of all disability-adjusted life years globally. In Norway, approximately 10,000 patients are admitted to hospital annually due to trauma, with 66% being male. The mean age is 43 years for male and 48 years for female, indicating a relatively young patient population compared to other medical cohorts. The socioeconomic and functional implications of trauma are significant. With the expected demographic shift toward an aging population in Norway, the incidence of trauma among older adults is also expected to increase, placing greater demands on in-hospital trauma and rehabilitation services. Socioeconomic status, gender and age have been identified as key predictors of long-term outcomes following trauma, with female and individuals with lower education levels or ongoing compensation claims often reporting poorer outcomes.
While mortality rates are decreasing due to advancements in trauma systems, prevention strategies and medical care, a significant proportion of trauma survivors experience longterm disabilities, reduced quality of life, and difficulties in returning to work. These consequences impose substantial burdens on individuals, families, and society. Considering these issues, a shift in focus is needed-from survival alone to long-term functional recovery and quality of life after trauma.
Severe trauma often requires long-term follow-up, both physically and psychosocially. Traditional follow-up is often fragmented and not tailored to individual needs. Digital patient monitoring and tailored information have the potential to improve patient pathways, but knowledge about how these are experienced by patients, relatives, and healthcare professionals is limited.
This study aims to investigate how early rehabilitation and patient-centred care pathways can improve short and long-term outcomes for trauma patients. The objectives of the POSTRAUMA-trial is to assess the efficacy of a tailored patient information and patient managed outpatient digital follow-up (I-POD), as an adjunct to standard treatment according to the national guidelines in the National Trauma Plan (NTP) among adult trauma patients in Norway. The main research question is whether participants in the intervention group have less disability and improved health-related quality of life 6 months after the accident compared to the control group which receives standard treatment alone?
The latter part of the trial is a qualitative study which will follow the consolidated criteria for reporting qualitative studies (COREQ). SI will through in-dept and semi-structured interviews explore the participants experiences following trauma in general, and more specific to evaluate how the written patient information and digital follow-up was perceived. The SI will encourage the participants to talk about issues regarding this by asking open-ended questions in one-to-one interviews. The illness trajectory framework will be used as a theoretical framework, along with the WHOs International Classification of Functioning, Disability and Health (ICF) to ensure that preinjury, physical and biopsychosocial factors are evaluated.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Marianne Wesnes, Cand. med.
- 電話番号:+47 996 20 649
- メール:marianne.wesnes@helse-bergen.no
研究連絡先のバックアップ
- 名前:Geir Arne Sunde, Ph.d.
- 電話番号:+47 992 04 008
- メール:geir.arne.sunde@helse-bergen.no
研究場所
-
-
-
Bergen、ノルウェー、5021
- Surgical Department, Haukeland University hospital
-
コンタクト:
- Marianne Wesnes, Cand.med
- 電話番号:+47 996 20 649
- メール:marianne.wesnes@helse-bergen.no
-
コンタクト:
- Geir Arne Sunde, Ph.d
- 電話番号:+47 992 04 008
- メール:geir.arne.sunde@helse-bergen.no
-
副調査官:
- Marianne Wesnes, Cand.med
-
主任研究者:
- Geir Arne Sunde, Ph.d
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- 16 years or older
- Fulfils the national criteria for TTA and admitted to HUS following trauma
- Included in NTR database
- Able to give informed consent
Exclusion Criteria:
- 15 years or younger
- Not included in NTR database
- Deceased before discharge from the hospital.
- Not able to give informed consent
- Insufficient command of the Norwegian language
- Foreign tourists or nationals
- Suicide attempt or serious self-inflicted trauma
- Serious psychiatric disorders or serious ongoing substance abuse
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Control group
Standard treatment and follow up after trauma according to national guidelines in the National trauma plan. |
|
|
アクティブコンパレータ:Intervention group
Tailored patient information and patient-managed outpatient follow up as an adjunct to standard treatment according to national guidelines in the National trauma plan |
The objective of the POSTRAUMA-trial is to assess if the I-POD intervention combined with standard treatment according to national guidelines, lead to less disability measured by EQ5D-index, better health-related quality of life measured by EQ-VAS and increased return to studies and work compared to standard treatment after trauma.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
EuroQol five-dimension utility score (EQ5D-index) from baseline to 6 months after the trauma in both groups.
時間枠:From baseline to 6 months after the trauma
|
The primary objective is to assess the efficacy of the I-POD-intervention as an adjunct to standard treatment after trauma according to national guidelines in adult patients in Norway. The efficacy is measured as the primary endpoint: EuroQol five-dimension utility score (EQ5D-index) from baseline to 6 months after the trauma in both groups. EQ5D-index ranges from - 0,59 (worst score) to 1 (perfect health, best score). 0 equals death. Baseline is defined as the time of inclusion. The I-POD intervention is a tailored patient Information and Patient-managed Outpatient Digital follow-up treatment. |
From baseline to 6 months after the trauma
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
外傷後1か月、6か月、12か月における対照群と介入群の職場復帰(RTW)の差異(患者報告データによる1か月時点、および二分法(はい/いいえ)で測定されたNTRデータによる6か月および12か月時点)
時間枠:ベースラインから1か月、6か月、12か月
|
ベースラインから1か月、6か月、12か月
|
|
|
Differences in EuroQol five-dimension utility score (EQ5D-index) between the control group and the intervention group from baseline to 1 month and 12 months after the trauma.
時間枠:Baseline to 1 month and 12 months after the trauma
|
EQ5D-index ranges from - 0,59 (worst score) to 1 (perfect health, best score). 0 equals death. |
Baseline to 1 month and 12 months after the trauma
|
|
Differences in HRQoL between the control group and the intervention group from baseline to 1 month, 6 months and 12 months after the trauma, measured by EuroQol visual analogue scale (EQ-VAS).
時間枠:Baseline to 1 month, 6 months and 12 months after the trauma
|
The EQ-VAS (EuroQol Visual Analogue Scale) is a standard tool used with the EQ-5D health questionnaire to measure a person's self-rated overall health on a vertical scale from 0 (worst imaginable health) to 100 (best imaginable health). |
Baseline to 1 month, 6 months and 12 months after the trauma
|
協力者と研究者
捜査官
- 主任研究者:Geir Arne Sunde, Ph.d、Haukeland University hospital, Surgical Department
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Sharing of privacy data is not within the scope of the ethical approval granted by REK West.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。